Correlation Between Immix Biopharma and Oncorus
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Oncorus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Oncorus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Oncorus, you can compare the effects of market volatilities on Immix Biopharma and Oncorus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Oncorus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Oncorus.
Diversification Opportunities for Immix Biopharma and Oncorus
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Immix and Oncorus is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Oncorus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncorus and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Oncorus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncorus has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Oncorus go up and down completely randomly.
Pair Corralation between Immix Biopharma and Oncorus
Given the investment horizon of 90 days Immix Biopharma is expected to generate 0.25 times more return on investment than Oncorus. However, Immix Biopharma is 3.92 times less risky than Oncorus. It trades about 0.03 of its potential returns per unit of risk. Oncorus is currently generating about -0.15 per unit of risk. If you would invest 205.00 in Immix Biopharma on August 27, 2024 and sell it today you would lose (26.00) from holding Immix Biopharma or give up 12.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 3.75% |
| Values | Daily Returns |
Immix Biopharma vs. Oncorus
Performance |
| Timeline |
| Immix Biopharma |
| Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Immix Biopharma and Oncorus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Oncorus
The main advantage of trading using opposite Immix Biopharma and Oncorus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Oncorus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncorus will offset losses from the drop in Oncorus' long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |